Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen and Genomics Collaborative Announce Joint SNP Analysis Project

NEW YORK, Jan 8 – Qiagen Genomics and Genomics Collaborative have formed a collaboration to compare genetic profiles of patients who have poor reactions to drugs to those with no reported adverse events to metabolic enzymes, the companies announced Monday.

The companies expect to complete the project, in which Qiagen will provide its SNP genotyping services and Genomics Collaborative will offer its database of genetic samples, sometime this spring, the companies said. The companies plan to submit the results of the analysis for publication.

" We believe that drug companies will save costs and reduce the time associated with developing new drugs by having access to patient profiles that can predict individual patient response with regards to drug absorption, distribution, metabolism and excretion outcomes," William Hirschman, GCI's Vice President for Business Development, said in a statement.

The companies said their project is the “most extensive study of its kind ever conducted."

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.